New research from Ï㽶ÊÓƵ links air pollution nanoparticles to brain cancer.
Providing excellent care and the latest research to help patients
The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.
Brain cancer begins in stem cells, targeting them may prevent tumour growth
Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.
Late stage brain cancer cells are heterogeneous — they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.
Pioneering work to advance genomics and precision health treatments at the Research Institute of the Ï㽶ÊÓƵ Health Centre (RI-MUHC) has been rewarded by Génome Québec. Dr. Nada Jabado and Dr. Ruth Sapir-Hichhadze, the RI-MUHC scientists who received the reward, were among the winners of a nation-wide competition emphasizing precision treatments in genomics.
2017 Québec Science Discovery of the Year Award goes to the cancer-detection probe developed byÌýKevin Petrecca and Frédéric Leblond
Québec Science magazine’s 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.
A Brilliant Night has donated a total of $1.6 million since 2015
A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.
Canadian researchers have invented an intraoperative probe that reliably detects multiple types of tumour cellsÌý
Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by Canadian researchers.Ìý
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones.ÌýWhereas some types of tumor respond well to treatment, others such as glioblastomas – the most common and aggressive brain tumors – are known to recur and progress within short times from the diagnosis. Patients diagnosed with this type of cancer, and who undergo current standard treatment, have a median survival of 16 months.
A Brilliant Night raises $1 million for brain cancer research
A Brilliant Night raised an astounding $1 million for brain cancer research at its gala event on Oct. 19.
Inspiring event to raise money for brain cancer research
An evening filled with personal stories from those whose lives have been affected by brain cancer will once again contribute to the fight against the disease.
Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman
Ìý
With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.